This treatment with clodronate liposomes markedly reduced CHF-elevated macrophage expansion (Fig. 2) and inhibited CHF-increased proinflammatory cytokines including TNFα and IL-1β in SGs (Fig. 1). Here, TNF is linked to congestive heart failure.